Filing Flows › Nexalin Technology (NXL) › Q1 2025
Nexalin Technology (NXL) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 13, 2025
Nexalin Technology (NXL) reported revenue of $41K for the first quarter 2025 (Q1 2025), -48% from a year earlier and +51% from the quarter before.
Nexalin Technology, Q1 2025: revenue $41K (-48% year over year), net loss $2.0M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41K | +51% | -48% |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $41K in Q1 2025, down 48% year over year and up 51% from the previous quarter. Equipment was the largest line at 48% of revenue. Licensing Fee lost $4K year over year (down 20%), 11% of the total change.
Gross margin was 66.9%, down 21.4 points from a year earlier. Operating costs exceeded revenue by $2.0M, an operating margin of -4903.6%. Operating expenses grew 78% against a revenue fall of 48%. The fastest-growing cost line was Research & development (+284%). The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $2.8M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $637K of share-based compensation. Working capital and other items used $75K.
Questions
What was Nexalin Technology's revenue in the first quarter 2025?
Nexalin Technology (NXL) reported revenue of $41K for the first quarter 2025 (Q1 2025), -48% from a year earlier and +51% from the quarter before.
Source: Nexalin Technology 10-Q on SEC EDGAR.